Related Experiment Videos
3,4-Methylenedioxyamphetamine (MDA) self-administration and neurotoxicity
1Department of Psychology, Carleton University, Ottawa, Ontario.
Pharmacology, Biochemistry, and Behavior
|July 1, 1991
Summary
3,4-Methylenedioxyamphetamine (MDA) is moderately reinforcing in rats, but self-administration of low doses over time causes selective neurotoxicity, particularly affecting serotonin levels in the hippocampus.
Area of Science:
- Neuroscience
- Pharmacology
- Toxicology
Background:
- 3,4-Methylenedioxyamphetamine (MDA) exhibits stimulant and hallucinogenic properties.
- MDA has historical medical and current recreational uses.
Purpose of the Study:
- To investigate the reinforcing effects of MDA in a rat model.
- To evaluate the neurotoxic potential of MDA following self-administration.
Main Methods:
- Rats underwent self-administration of MDA at doses of 0.10, 0.05, and 0.025 mg/injection.
- Behavioral assessments included Fixed Ratio 1 (FR1) and Progressive Ratio (PR) schedules.
- Neurotoxicity was assessed using High-Performance Liquid Chromatography (HPLC) to measure neurotransmitter levels.
Main Results:
- MDA supported self-administration across all tested doses on the FR1 schedule.
- Lethal overdoses occurred at the highest dose (0.10 mg/injection).
- Progressive Ratio schedules indicated relatively low breakpoints, suggesting moderate reinforcing efficacy.
- HPLC analysis revealed significant serotonin (5-HT) depletion in the hippocampus post-self-administration.
Conclusions:
- MDA demonstrates moderate reinforcing properties in rats.
- Sustained self-administration of low MDA doses leads to selective neurotoxicity.
- Hippocampal serotonin depletion is a key neurotoxic effect observed.